Navigation Links
Orexigen Therapeutics to Present at Upcoming Investor Conferences
Date:2/7/2013

SAN DIEGO, Feb. 7, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will be presenting at two upcoming investor conferences. The details are as follows:The 15th Annual BIO CEO & Investor Conference Date:

Tuesday, February 12, 2013Time:

2:00 p.m. Eastern TimeLocation:

The Waldorf Astoria, New York2013 Leerink Swann Global Healthcare Conference Date:

Wednesday, February 13, 2013Time:

11:30 a.m. Eastern Time Location:

The Waldorf Astoria, New YorkThe BIO CEO & Investor Conference presentation will be webcast live. To access the webcast, please visit the Investor Relations section of the company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.

Orexigen Contact: McDavid Stilwell
VP, Corporate Communications and Business Development 
(858) 875-8629

Media Contact: Denise Powell
BrewLife
(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... HUATULCO , Mexique, July 3, 2015 /PRNewswire/ ... médicale continue cible les épidémies que sont l,hypertension, ... latine, par l,intermédiaire de plateformes éducatives gratuites et ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227033 ) , ... le diabète en ligne , Prendre en ...
(Date:7/3/2015)... , July 3, 2015  Obsidian HDS, the developer ... online service for the management of data on pharmaceutical ... that PharmaShine now includes the 2014 Open Payments General ... Services on June 30. The data disclosed on Open ... between industry and providers totaling $6.49 billion and is ...
(Date:7/2/2015)... -- BGI a annoncé aujourd,hui que son laboratoire ... à Hong Kong avait ...  (Collège des pathologistes américains, ou CAP). Les installations ... constituent le premier laboratoire clinique de séquençage ... CAP en Chine, car il satisfait les normes ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2
... Biomarkers and Rapidly Improves Cognition in two,distinct ... June 7, 2007 - Prana Biotechnology,Limited (NASDAQ: ... on the research and development of treatments ... present,new data on Prana's lead Alzheimer's disease ...
... , Waltham, Mass., June 7, 2007 – Dynogen ... Phase 1b trial of DDP733 for gastroesophageal,reflux disease ... for DDP733 as a treatment for nocturnal GERD,(NGERD). ... achieved statistical,significance over placebo on the primary endpoint ...
Cached Medicine Technology:Prana Biotechnology Presents New Key Findings on PBT2 2Prana Biotechnology Presents New Key Findings on PBT2 3Prana Biotechnology Presents New Key Findings on PBT2 4Prana Biotechnology Presents New Key Findings on PBT2 5Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 2Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 3
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie ... 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of ... and practical points of investigating these types of cases. , Each year, New ...
(Date:7/3/2015)... Lewisville, TX (PRWEB) , ... July 03, 2015 , ... ... in the United States, named Mariah N. Manzanares, MD as the new Medical Director ... the new facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is currently running a ... those of celebrities will have the opportunity to get 10% discount on orders that ... people do not have to use coupon codes or remember redemption codes. , ...
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by ... obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war on obesity ... society right now," Becic said. "We must understand the magnitude of this discovery. For ...
(Date:7/2/2015)... ... ... in full swing, Americans are flocking to Canada’s many lakes to reel in their fair ... world, and it’s easy to understand why. From the Pacific Northwest Coast of British Columbia ... is a huge industry, and Americans make up the vast majority of anglers from outside ...
Breaking Medicine News(10 mins):Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... appear to approach adult levels of performance on many ... 12, according to a new study coordinated by ... NIH Magnetic Resonance Imaging (MRI) Study of Normal Brain ... 500 healthy American children, from birth to age 18. ...
... similarities, there are vast differences in the areas they cover. ... embryo research are very different from the equally complex and ... organs and tissues after death. ,The BMA is ... able to deal effectively with these two distinct and very ...
... accident, skull separating from her spine, has survived to tell ... ,A car crash slammed her into the dashboard. Her ... and other internal organs remained intact. The rare condition is ... no control over her head. ,Surgeons said her ...
... Address, he was in the early stages of a deadly ... of Texas researchers, has revealed. ,Some historians, who ... that the President was suffering from a very mild form ... ,However, his illness, researchers wrote in their study, ...
... Institute and Fred Hutchinson Cancer Research Center report ... , does not effectively prevent prostate cancer. ... between beta-carotene, an antioxidant related to lycopene, and ... ,It is disappointing, since lycopene might have ...
... Ten years after the then US President set a target ... remains a distant dream . ,"We have learned ... is," says immunologist Wayne Koff, senior vice president for research ... ,Global spending for HIV vaccine research increased from $186 ...
Cached Medicine News:Health News:NIH Study Normal Brain Development in Children Across US 2Health News:NIH Study Normal Brain Development in Children Across US 3Health News:NIH Study Normal Brain Development in Children Across US 4Health News:30-year-old Woman Survives 'internal Decapitation' 2Health News:Study Finds That Lincoln Suffered from Smallpox During Gettysburg Speech 2Health News:Tomatoes are Not So Effective in Preventing Prostate Cancer 2Health News:AIDS Vaccine Still a Long Way Off 2
Head-worn Loupe KF Titanium the teleloupe system is mounted on a special frame with straight temples and an elastic headband....
... higher magnification for advanced surgical procedures. Prismatic ... at the highest magnification. 3.5x, 4.5x and ... color rendition is ideal for surgical applications. ... produce a superior image. The compact abd ...
... The XL Advantage delivers higher magnification ... a crisp, true image, even at the ... to edge clarity and precise color rendition ... treated with an anti-reflective coating produce a ...
... loupes are higher magnification ... edge to edge clarity ... ,Keeler Prismatic loupes are ... with anti reflective coating ...
Medicine Products: